Redevelopment and validation of the SYNTAX score II to individualise decision making between percutaneous and surgical revascularisation in patients with complex coronary artery disease: secondary analysis of the multicentre randomised controlled SYNTAXES trial with external cohort validation
- 8 October 2020
- journal article
- research article
- Published by Elsevier BV in The Lancet
- Vol. 396 (10260), 1399-1412
- https://doi.org/10.1016/s0140-6736(20)32114-0
Abstract
No abstract availableThis publication has 60 references indexed in Scilit:
- The rationale for Heart Team decision-making for patients with stable, complex coronary artery diseaseEuropean Heart Journal, 2013
- Strategies for Multivessel Revascularization in Patients with DiabetesThe New England Journal of Medicine, 2012
- Determinants of variations in coronary revascularization practicesCMAJ : Canadian Medical Association Journal, 2011
- A crucial factor in shared decision making: the team approachThe Lancet, 2011
- Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposalTrials, 2010
- Estimating GFR Using the CKD Epidemiology Collaboration (CKD-EPI) Creatinine Equation: More Accurate GFR Estimates, Lower CKD Prevalence Estimates, and Better Risk PredictionsAmerican Journal of Kidney Diseases, 2010
- Percutaneous Coronary Intervention versus Coronary-Artery Bypass Grafting for Severe Coronary Artery DiseaseThe New England Journal of Medicine, 2009
- Clinical Judgment and Treatment Options in Stable Multivessel Coronary Artery Disease: Results From the One-Year Follow-Up of the MASS II (Medicine, Angioplasty, or Surgery Study II)Journal of the American College of Cardiology, 2006
- The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: Design, rationale, and run-in phaseAmerican Heart Journal, 2006
- From subgroups to individuals: general principles and the example of carotid endarterectomyThe Lancet, 2005